Dr. Katharina Shaw explores type 1 interferon antagonism as a promising treatment for recalcitrant cutaneous lupus and dermatomyositis, offering new insights into managing these challenging connective tissue diseases.
Topics Covered:
- Type 1 interferon antagonism
- Advancements in treating recalcitrant cutaneous lupus
- Dermatomyositis management strategies
Explore Related Resources: